{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:59:23Z","timestamp":1779116363732,"version":"3.51.4"},"reference-count":55,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015622","name":"Ministerul Cercet\u0103rii \u015fi Inov\u0103rii","doi-asserted-by":"publisher","award":["61PCCDI\/2018 PN-III-P1-1.2-PCCDI-2017-034"],"award-info":[{"award-number":["61PCCDI\/2018 PN-III-P1-1.2-PCCDI-2017-034"]}],"id":[{"id":"10.13039\/501100015622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunology Research"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>\n                    <jats:italic>Introduction<\/jats:italic>\n                    . Endogenously produced antiganglioside antibodies could affect the evolution of cutaneous melanoma. Epidemiological and experimental evidence suggest \u201cchronic inflammation\u201d to be one of the hallmarks in skin cancers. The aim of the study was to characterize the relation between antiganglioside antibodies and inflammation in cutaneous melanoma focusing on gangliosides GM1, GM2, GM3, GD1a, GD1b, GT1b, GQ1b.\n                    <jats:italic>Material and Method<\/jats:italic>\n                    . We performed an observational study that included 380 subjects subdivided into three groups: patients with metastatic melanoma (170 cases), patients with primary melanoma (160 cases), and healthy subjects (50 subjects). The assessment of antiganglioside antibodies, IgG, and IgM classes, against \u2010GM1, \u2010GM2, \u2010GM3, \u2010GD1a, \u2010GD1b, \u2010GT1b, \u2010GQ1b was performed using immunoblot technique (EUROLine kit).\n                    <jats:italic>Results<\/jats:italic>\n                    . The presence of IgG and IgM antiganglioside antibodies in primary melanoma was (%), as follows: anti\u2010GM1 (5.0 and 13.1), \u2010GM2 (1.8 and 18.1), \u2010GM3 (0.6 and 5.6), \u2010GD1a (0.6 and 15.0), \u2010GD1b (3.7 and 10.7), \u2010GT1b (0.0 and 13.1), \u2010GQ1b (0.0 and 5.0). In metastatic melanoma, the level of antiganglioside antibodies was significantly lower compared with primary melanoma (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.05), while in the control group they were absent. Antiganglioside antibodies anti\u2010GM1 and \u2010GD1a were positively correlated, while anti\u2010GM3, \u2010GD1b, and \u2010GT1b were negatively associated with the inflammatory markers, interleukin 8 (IL\u20108), and C reactive protein (CRP).\n                    <jats:italic>Conclusions<\/jats:italic>\n                    . Tumour ganglioside antigens generate an immune response in patients with primary melanomas. The host\u2019s ability to elaborate an early antiganglioside response could be considered as a defence mechanism, directed toward eliminating a danger signal from the tumour microenvironment. Antiganglioside antibodies associated with inflammation markers could be used as diagnostic, monitoring, and treatment tools in patients with cutaneous melanoma.\n                  <\/jats:p>","DOI":"10.1155\/2020\/2491265","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T19:32:56Z","timestamp":1597347176000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma"],"prefix":"10.1155","volume":"2020","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-2575","authenticated-orcid":false,"given":"Corina Daniela","family":"Ene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4983-7648","authenticated-orcid":false,"given":"Mircea","family":"Tampa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7858-5502","authenticated-orcid":false,"given":"Ilinca","family":"Nicolae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4195-1414","authenticated-orcid":false,"given":"Cristina Iulia","family":"Mitran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7455-7344","authenticated-orcid":false,"given":"Madalina Irina","family":"Mitran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-8805","authenticated-orcid":false,"given":"Clara","family":"Matei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4200-3069","authenticated-orcid":false,"given":"Ana","family":"Caruntu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4530-7965","authenticated-orcid":false,"given":"Constantin","family":"Caruntu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona Roxana","family":"Georgescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"e_1_2_10_1_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R003996"},{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-015-1103-7"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00300"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2011.337"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206881"},{"key":"e_1_2_10_6_2","article-title":"Ganglioside GD1a, present in ovarian cancer cells, ascites and sera of patients elicits endogenous IgM response","volume":"1","author":"Ravindranath M. H.","year":"2005","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107807"},{"key":"e_1_2_10_8_2","unstructured":"EneC. D.andNicolaeI. MurphM. Gangliosides and Antigangliosides in Malignant Melanoma Melanoma - Current Clinical Management and Future Therapeutics 2015 Mandi Murph IntechOpen ISBN 978-953-51-2036-0."},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-07-1057"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwp015"},{"key":"e_1_2_10_11_2","first-page":"86","article-title":"Antibodies against GM1 gangliosides associated with metastatic melanoma","volume":"21","author":"Nicolae C. D.","year":"2013","journal-title":"Acta Dermatovenerologica Croatica"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.201600705"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-560"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9735"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51333-3"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2018.06.014"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503658102"},{"key":"e_1_2_10_18_2","first-page":"221","article-title":"Cytokine pattern for improving immuno-score in melanoma patients","volume":"46","author":"Neagu M.","year":"2016","journal-title":"European Journal of Immunology"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2015.1035593"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0868-z"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1997.273.4.E720"},{"key":"e_1_2_10_22_2","first-page":"456","article-title":"The role of interleukin-8 in inflammation and mechanisms of regulation","volume":"64","author":"Bickel M.","year":"1993","journal-title":"Journal of Periodontology"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/107940"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.22543\/7674.52.P169175"},{"key":"e_1_2_10_25_2","first-page":"339","article-title":"Immunohistochemical mismatch in a case of rhabdomyoblastic metastatic melanoma","volume":"59","author":"Dumitru A. V.","year":"2018","journal-title":"Romanian Journal of Morphology and Embryology"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/prs.0000000000002367"},{"key":"e_1_2_10_27_2","first-page":"1005","article-title":"Melanoma: epidemiology, risk factors, pathogenesis Diagnosis and Classification","volume":"28","author":"Rastrelli M.","year":"2014","journal-title":"In Vivo"},{"key":"e_1_2_10_28_2","first-page":"163","article-title":"Melanoma development: current knowledge on melanoma pathogenesis","volume":"27","author":"Lugovi\u0107-Mihi\u0107 L.","year":"2019","journal-title":"Acta Dermatovenerologica Croatica"},{"key":"e_1_2_10_29_2","first-page":"817","article-title":"A challenging case of ocular melanoma","volume":"56","author":"Costache M.","year":"2015","journal-title":"Romanian Journal of Morphology and Embryology"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.180197"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00130404-200209000-00009"},{"key":"e_1_2_10_32_2","first-page":"574","article-title":"Inhibition of subcutaneous growth of Ehrlich ascites carcinoma (EAC) tumor by post-immunization with EAC-cell gangliosides and its anti-idiotype antibody in relation to tumor angiogenesis, apoptosis, cell cycle and infiltration of CD4+, CD8+ lymphocytes, NK cells, suppressor cells and APC-cells in tumor","volume":"49","author":"Mondal B.","year":"2011","journal-title":"Indian Journal of Experimental Biology"},{"key":"e_1_2_10_33_2","article-title":"Supression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody","volume":"20","author":"Sahal S.","year":"2001","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/hyb.1998.17.431"},{"key":"e_1_2_10_35_2","article-title":"Innate immune response to gangliosides of primary melanoma favors danger hypothesis","volume":"45","author":"Ravindranath M. H.","year":"2004","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0b013e3282f43acf"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(01)00300-5"},{"key":"e_1_2_10_38_2","first-page":"1277","article-title":"Serum total gangliosides level: clinical prognostic implication","volume":"52","author":"Nicolae I.","year":"2011","journal-title":"Romanian Journal of Morphology and Embryology"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2012.17"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2017.10.003"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-S4-P25"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00875"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10719-019-09885-z"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/904876"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00754"},{"key":"e_1_2_10_46_2","first-page":"149","article-title":"The relationship between interleukin-8 and Ki67 in cutaneous malignant melanoma","volume":"7","author":"Anghel A. E.","year":"2015","journal-title":"HVM Bioflux"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2016.1155996"},{"key":"e_1_2_10_48_2","first-page":"10911","article-title":"Interleukin 8 - major player in cutaneous melanoma metastasic process","volume":"20","author":"Anghel A. E.","year":"2015","journal-title":"Romanian Biotechnological Letters"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00851"},{"key":"e_1_2_10_50_2","first-page":"370","article-title":"Interleukin 8 and diabetic nephropathy","volume":"7","author":"Ene C. D.","year":"2015","journal-title":"Human and Veterinary Medicine"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00348"},{"key":"e_1_2_10_52_2","article-title":"GD1b, GT1b, GQ1b gangliosides mediate the progression of melanoma","volume":"133","author":"Nicolae C.","year":"2013","journal-title":"The Journal of Investigative Dermatology"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.31925\/farmacia.2018.5.11"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4287"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2016.234"}],"container-title":["Journal of Immunology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/jir\/2020\/2491265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jir\/2020\/2491265.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2020\/2491265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:16:48Z","timestamp":1762093008000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2020\/2491265"}},"subtitle":[],"editor":[{"given":"Iulia Dana","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1155\/2020\/2491265"],"URL":"https:\/\/doi.org\/10.1155\/2020\/2491265","archive":["Portico"],"relation":{},"ISSN":["2314-8861","2314-7156"],"issn-type":[{"value":"2314-8861","type":"print"},{"value":"2314-7156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"2020-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2491265"}}